Intrauterine Device – Levo­nor­gestrel 52 mg [Design Issues]

posted by marianna.macera – Brazil, 2021-06-30 17:04 (1468 d 19:28 ago) – Posting: # 22443
Views: 3,518

Dear All,

Could anyone make a suggetion about number of subjects to a Bioequivalence / Bioavailability studie of a intrauterine system contening Levonorgestrel? We are following FDA- "Draft Guidance on Levonorgestrel" and was used CV 35.5%, from a clinical study phase II, it is that possible?

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,694 registered users;
106 visitors (1 registered, 105 guests [including 13 identified bots]).
Forum time: 12:32 CEST (Europe/Vienna)

Anyone who conducts an argument by appealing to authority
is not using his intelligence;
he is just using his memory.    Leonardo da Vinci

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5